video corpo

aview:LCS

aview:LCS

aview:LCS

Product catalog summary
Introduction
Coreline's aview:LCS is an AI-based CAD system designed to detect and diagnose lung nodules on chest CT images, adhering to LUNG-RADS guidelines. It facilitates patient communication through automatically generated readings and reports. The system is part of lung cancer screening projects in five EU countries, including Korea and Germany, for investigational use only.
Performance Validation
Clinical trials at Asan Hospital, Seoul, demonstrated a sensitivity of 97% and specificity of 76% (ROC AUC 0.93). The AI system ranked second in sensitivity when compared with five reading specialists in the Moscow LS verification.
Key Features
The AI technology detects small nodules, provides 3D size and volume information, and classifies nodules as solid, part-solid, or non-solid. It generates quantitative analysis reports and tracks changes in nodules over time, aiding in assessing growth and risk.
3D Clinical Viewer
The system offers 3D visualization of lungs and nodules, enhancing clinical overview and patient communication. It automatically generates detailed analysis reports aligned with Lung-RADS categories.
LCS PLUS
Coreline's AVIEW LCS Plus integrates detection and analysis of lung cancer, chronic obstructive pulmonary disease (COPD), and coronary artery disease from a single low-dose chest CT examination. It quantifies results for emphysema and coronary artery calcification, providing a comprehensive solution for the 'Big 3' diseases.
Conclusion
The LCS and LCS PLUS systems offer advanced AI-based solutions for automatic lung nodule analysis and multi-disease detection, enhancing diagnostic accuracy and patient communication.
See more

Catalog excerpts

aview:LCS-1

LCS Deep learning AI-based automatic lung nodule analysis solution Lung Cancer Screening

 Open the catalog to page 1
aview:LCS-2

We detect and analyze lung nodules with deep learning AI technology. core:line's aview:LCS is the AI CAD system to detect and diagnose lung nodules on chest CT images according to the LUNG-RADS. Patient communication becomes easier with the automatically generated readings and reports. 4-IN THE LUNG RUN in five EU countries, including K-LUCAS of korea and HANSE of Germany, a lung cancer screening project Selected as a solution.

 Open the catalog to page 2
aview:LCS-3

Performance Validation Sensitivity 97%, Specificity 76% Pulmonary nodule detection performance 91% Evaluation results of the clinical trials in Korea Nodule sensitivity Nodule sensitivity False Positive / Scan False Positive / Scan 346 cases at Asan Hospital, Seoul Sensitivity 0.97, specificity 0.76 (ROC AUC 0.93) Moscow LS Verification From the result of comparing the performance of AI with 5 Reading specialists from the Moscow LS verification, it proved the 2nd best performance in terms of sensitivity (5 Reading specialists + AI). Reading specialist

 Open the catalog to page 3
aview:LCS-4

Optimize your reading time Increase the accuracy of the result AI-based automatic analysis Deep learning AI technology detects even the smallest nodules that the reader might miss. It provides 3D size and volume information by segmenting nodules, and automatically classifies solid, part-solid, non-solid. It calculates the analyzed quantitative results to generate a report. Follow-up It matches nodules from previous and follow-up examinations to provide changes in nodule by measuring the volume of lung nodules to see the growth and risk of nodules.

 Open the catalog to page 4
aview:LCS-5

Provides detailed results that can help improve patient communication Detailed analysis reports It can also generate patient-facing detailed analysis reports automatically, giving back more information to the patient. Reading reports align with the Lung-RADS category and are assorted by user-confirmed nodules from its highest scores at the top. 3D clinical viewer 3D visualization of the lung and nodule for clinical overview. It can accurately identify the location and size of the nodule which can help with patient communication.

 Open the catalog to page 5
aview:LCS-6

LCS PLUS Analysis for lung cancer, chronic obstructive pulmonary disease and coronary artery disease from a single examination Coreline's AVIEW LCS Plus provides integrated detection and fully automatic analysis of *Big 3 diseases from a single examination. It automatically generates a pulmonary nodule readout for lung cancer diagnosis and quantifies the quantitative results of emphysema and coronary artery calcification. It is the Solution that can detect three diseases at the same time through low-dose chest CT image with CT kernel conversion AI technology. *Marjolein A Heuvelmans, Marleen...

 Open the catalog to page 6
aview:LCS-7

Converts low-dose chest CT images taken for lung cancer screening, analyzes emphysema, and reports the results automatically. Coronary Artery Calcium Score Converts low-dose chest CT images taken for lung cancer screening to find calcium in the coronary arteries and automatically reports the results.

 Open the catalog to page 7
aview:LCS-8

LCS Deep learning AI-based automatic lung nodule analysis solution LCS PLUS Deep learning AI-based automatic analysis solution for big 3 diseases from a single examination FDA Cleared Staying ahead of symptoms

 Open the catalog to page 8

All Coreline catalogs and technical brochures

  1. aview: RT ACS

    4  Pages

  2. aview: CAC

    8  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.